Accretion Nutraveda IPO
Open SmeCurrent GMP
₹68 (+52.71%)
Price Band
₹ 122 – 129
Lot Size
1000
Issue Size
₹25 Cr
Minimum Investment
₹258000 (2000 Shares)
Listing Date
04 February 2026
Subscription
1.91x
About the Company
Incorporated in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and Nutraceutical products across a wide range of dosage forms, including tablets, capsules, oral liquids, powders, oils, and external applications such as balms, creams, and gels.
The Company operates as a Contract Development and Manufacturing Organization (CDMO), catering to both domestic and international markets. Its international presence spans countries such as Sri Lanka, Singapore, and the United States of America.
Accretion Nutraveda integrates classical Ayurvedic principles with contemporary nutraceutical science to develop products targeting key therapeutic and wellness segments, including:
- Liver care
- Women’s health
- Bone and joint health
- Cognitive health
- Respiratory wellness
Business Verticals
- Domestic Sales and Merchant Exports (Loan License Basis):
This vertical remains the primary revenue contributor, accounting for 96.62% of total revenue in FY 2024–25. - Direct Exports:
Direct exports contributed 38% of revenue, demonstrating consistent growth and reflecting the Company’s expanding international footprint.
Manufacturing Infrastructure
Accretion Nutraveda operates a state-of-the-art manufacturing facility in Gujarat, spread across approximately 10,763 square feet. The facility is equipped with modern infrastructure, including:
- 13 Air Handling Units (AHUs)
- Segregated processing areas for different product categories
- Dedicated quality control and quality assurance systems
The manufacturing unit complies with stringent regulatory and quality standards and holds the following certifications:
- GMP and WHO-GMP
- FSSC 22000
- ISO 9001:2015
- ISO 45001:2018
- Halal Certification
- FSSAI License
Promoters
- Mr. Mayur Popatlal Sojitra
- Mr. Ankurkumar Shantilal Patel
- Mr. Paraskumar Vinubhai Parmar
- Mr. Hardik Mukundbhai Prajapati
- Mr. Harshad Nanubhai Rathod
- Mr. Vivek Ashok Kumar Patel
Promoters Holding
Holding Pre Issue
100.00%
Holding Post Issue
73.48%
Objects of the Issue
The Company Accretion Nutraveda IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Purchase of Machineries for Automation in existing Manufacturing unit
- Purchase of Machineries for New Manufacturing Setup
- Funding working capital requirements of our company
- General corporate purpose
Address / Contact Info
Accretion Nutraveda Ltd.
27 Xcelon Industrial Park-1
Vasna-Chacharwadi, TaSanand,
Ahmedabad, Gujarat, 382213
Phone: +91- 9904366177
Email: compliance@accretionnutraveda.com
Website: http://www.accretionnutraveda.com/
IPO Snapshot
IPO Timeline (Tentative)
IPO Open Date
Wednesday, 28 January 2026
IPO Close Date
Friday, 30 January 2026
Basis of Allotment
Monday, 02 February 2026
Initiation of Refunds
Tuesday, 03 February 2026
Credit of Shares to Demat
Tuesday, 03 February 2026
Listing Date
Wednesday, 04 February 2026 — NSE & BSE
Important Dates
Open Date
28 January 2026
Close Date
30 January 2026
Basis Of Allotment
02 February 2026
Listing Date
04 February 2026
Financial Performance (₹ in Crores)
| Particular | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 16.35 | 10.86 | 4.64 | 4.06 |
| Revenue | 14.07 | 16.06 | 5.2 | 3.07 |
| Profit After Tax | 2.33 | 2.61 | 0.82 | 0.28 |
| Net Worth | 8.26 | 5.35 | 1.08 | 0.26 |
| Reserve & Surplus | 2.95 | 4.86 | 0.72 | -0.1 |
| Total Borrowings | 4.43 | 3.86 | 2.17 | 1.97 |
EPS Pre
4.91%
EPS Post
6.44%
P/E Pre
26.27
P/E (Post Issue)
20.02x
Company Financial Information
KPI Information (₹ in Crores)
| Particular | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| ROE % | 68.54 | 81.22 | 121.94 | 228.56 |
| ROCE % | 49.09 | 36.98 | 28.98 | 12.51 |
| Debt / Equity | 0.54 | 0.72 | 2 | 7.5 |
| RoNW % | 56.5 | 48.85 | 75.75 | 106.66 |
| PbW | 0 | 0 | 0 | 0 |
| Pat Margin % | 16.59 | 16.33 | 16.42 | 9.67 |
Return Ratio
IPO Reservations
| Category | Shares Offered | Shares Offered % | Max Allotee |
|---|---|---|---|
| Qualified Institutions | 364000 | 28.44 | 0 |
| Non-Institutional | 276000 | 21.56 | 0 |
| BNII | 184000 | 14.38 | 0 |
| SNII | 92000 | 7.19 | 0 |
| Retail Investors | 640000 | 50 | 0 |
| Total | 1280000 | 100 | 0 |
Subscription Status ( Fri, 30 Jan 26 01:59 PM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 364000 | 367000 | 1.01x |
| Non-Institutional | 276000 | 669000 | 2.42x |
| Retail Investors | 640000 | 1404000 | 2.19x |
| Total | 1280000 | 2440000 | 1.91x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Peer Comparision
| Company | Face Value | PE Ratio | EPS Basic | EPS Diluted | RoNW | Net Assets |
|---|---|---|---|---|---|---|
| Accretion Nutraveda Ltd | 10 | 0.00 | 4.73 | 4.73 | 56.50 | 16.74 |
| Walpar Nutritions Ltd. | 10 | 3.30 | 1.06 | 1.06 | 6.24 | 17.05 |
| Influx Healthtech Ltd | 10 | 46.99 | 4.81 | 4.81 | 11.10 | 38.98 |
Lot Size & Investment Details
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | 258,000.00 |
| Retail (Max) | 2 | 2,000 | 258,000.00 |
| S-HNI (Min) | 3 | 3,000 | 387,000.00 |
| S-HNI (Max) | 7 | 7,000 | 903,000.00 |
| B-HNI (Min) | 8 | 8,000 | 1,032,000.00 |
Registrar
Kfin Technologies Limited
04067162222, 04079611000
reachus@kfintech.com
https://www.kfintech.com
Book Running Lead Managers
- Sobhagya Capital Options Ltd
RHP Document
DRHP Document
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Accretion Nutraveda IPO is a Book-building IPO worth ₹25 crores. The price band is ₹122 to 129 per share. The IPO opens on Wed, Jan 28, 2026 and closes on Fri, Jan 30, 2026. It will be listed on BSE and NSE. Kfin Technologies Limited is the registrar.
The Accretion Nutraveda IPO opens on Wed, Jan 28, 2026 and closes on Fri, Jan 30, 2026
Accretion Nutraveda IPO Price Band is ₹122 to 129.
Accretion Nutraveda IPO lot size is 1000, and the minimum amount required for application is ₹258000.
The minimum investment for Accretion Nutraveda IPO is approximately ₹258000 based on the upper price band.
To apply for the Accretion Nutraveda IPO , investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of Fri, Jan 30, 2026. After submission, funds are blocked until the basis of allotment of Accretion Nutraveda IPO is finalised.
Accretion Nutraveda IPO issue size is ₹25 crores.
Accretion Nutraveda IPO allotment date is Sat, Jun 27, 2026.
The registrar for Accretion Nutraveda IPO is Kfin Technologies Limited. Investors can go to Kfin Technologies Limited website for IPO allotment status, refund processing, and other queries related to Accretion Nutraveda IPO through their official website or helpline.
The Accretion Nutraveda IPO GMP (Grey Market Premium) is ₹68 as of Wed, Feb 4, 2026. Based on the upper price band of ₹129 per share, the estimated Accretion Nutraveda IPO listing price is ₹197, indicating a potential listing gain of approximately 31% over the issue price.